期刊文献+

玻璃酸钠关节腔注射治疗膝关节骨关节炎临床疗效观察 被引量:11

下载PDF
导出
摘要 目的观察玻璃酸钠关节腔注射治疗膝关节骨关节炎的临床疗效。方法统一选择髌骨上缘水平线与髌骨外缘的垂直线的交点作为膝关节腔的穿刺点,每个关节每次注入玻璃酸钠25mg(2.5ml),每7天1次,5次1个疗程,6个月重复治疗1个疗程。结果玻璃酸钠关节腔注射对膝关节骨关节炎具有较好临床疗效,且完成2个疗程疗效优于1个疗程,完成3个疗程疗效优于1个和2个疗程。结论关节腔注射外源性玻璃酸钠具有缓解或消除疼痛、改善或恢复关节功能、延缓病情发展的治疗效果,主要适用于早中期患者,但不适用于关节间隙明显狭窄或不对称、严重的软骨破坏和骨赘形成、关节内外翻畸形等晚期病例。定期按疗程治疗有助于稳定病情、巩固和提高疗效。
出处 《西部医学》 2010年第8期1420-1421,共2页 Medical Journal of West China
  • 相关文献

参考文献3

  • 1骨关节炎诊治指南(2007年版)[J].中华骨科杂志,2007,27(10):793-796. 被引量:1972
  • 2徐海林.关节功能评分//王亦璁.骨与关节损伤[M].第4版.北京:人民卫生出版社,2007:730-742.
  • 3Moreland LW.Intro-articular hyaluronan(hyaluronic acid)and hylans for the treatment of osteoarthritis:mechanisms of action[J].Arthriti Res Ther,2003,5(2):54-67.

二级参考文献23

  • 1Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum, 2000, 43: 1905-1915.
  • 2Schnitzer TJ, American College of Rheumatology. Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage, 2002, 23(4 Suppl): S24-34.
  • 3Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅱ. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum, 1995, 38:1541-1546.
  • 4Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅰ. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum, 1995, 38: 1535-1540.
  • 5Simon LS, Lipman AG, Jacox AK, eds. Pain in osteoarthritis, rheumatoid arthritis and juvenile chronic arthritis. 2nd ed. Glenview (IL): American Pain Society (APS), 2002. 179.
  • 6Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2007, 66: 377-388.
  • 7Zhang W, Doherty M. EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology. Br J Sports Med, 2006, 40: 664-669.
  • 8Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2000, 59: 936-944.
  • 9Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2005, 64: 669-681.
  • 10Chevalier X, Marre JP, de Butler J, et al. Questionnaire survey of management and prescription of general practitioners in knee osteoarthritis: a comparison with 2000 EULAR recommendations. Clin Exp Rheumatol, 2004, 22: 205-212.

共引文献1971

同被引文献95

引证文献11

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部